相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

人体脂肪组织11β-基固醇脱酶1型抑制,没有太基症由克洛富特里本,一个伪不可逆的酶抑制剂

Guohua An¹, Julio A Gutierrez², Cele Abad-Zapatero³

¹University of Iowa, Iowa City, Iowa, USA.

Clinical and translational science

|November 15, 2025

概括

与其他抑制剂不同的是,HSD-1抑制剂克洛富特里本有效地减少脂肪组织中的活性皮质醇,而无需太基肌过敏. 它独特的结合机制表明,在治疗过多的葡萄皮质激素治疗条件方面,它具有更好的临床效用.

科学领域:

内分泌学在内分泌学.
药理学药理学是指药理学的学科.
代谢疾病代谢疾病

背景情况:

11β-hydroxysteroid脱酶1型 (HSD-1) 抑制剂的目的是治疗过多的葡萄糖皮质体.
快速反应 (快速减少的药物反应) 限制了一些HSD-1抑制剂在脂肪组织中的临床效用.

研究的目的:

为了调查HSD-1抑制剂克洛富特里本是否表现出脂肪分泌.
描述克洛富与HSD-1的结合动力学和分子相互作用.

主要方法:

微透析用于测量 clofutriben 管理期间患有 2 型糖尿病和肥胖症的个体皮下脂肪组织中的 HSD-1 活性.
使用表面等离子体共振和分子对接来分析克洛富特里本与人类HSD-1的结合.

主要成果:

克洛富特里本在脂肪组织中表现出对HSD-1活性的剂量依赖抑制.
没有证据表明在稳定状态下使用克洛富特里本剂量时观察到分泌力衰退.
克洛富特里本表现出快速启动,减缓的结合动力学,与HSD-1和NADPH形成稳定的三元复合体.

结论:

克洛富特里本在脂肪组织中有效抑制HSD-1,而不会诱导太基肌过敏.
它独特的结合机制,涉及三元复合体,可能是其有利的药理学特征的基础.
克洛富里本显示出治疗葡萄糖皮质激素过量的疾病的潜力.

关键词:

这就是HSD11B1的原因.临床试验临床试验临床试验临床试验临床试验皮质醇是一种皮质醇.酶抑制剂是一种酶抑制剂.葡萄糖皮质类药物是什么药理动力学是药理动力学的一个方面.

更多相关视频

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

相关概念视频

Lipid Catabolism

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...